Floatz logo

EXEMESTANE

Tuberous Sclerosis Complex (TSC)

SAPU NANO (US) LLCSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Tuberous Sclerosis Complex (TSC) cohort.

Asset / SponsorPhaseRating
Everolimus
Hospices Civils de Lyon
Phase 3BBB
Rapamycin
Katarzyna Kotulska
Phase 3BBB
NPC-12G
Nobelpharma
Phase 3BB
Carbamazepine
GRIN Therapeutics, Inc.
Phase 3BB
Ganaxolone
Marinus Pharmaceuticals
Phase 3BB

View all 23 →

Same molecule, other indications

EXEMESTANE is also rated in:

estrogen-receptor positive breast cancerDormant
BBB
Indicative ·
75 / 100
View asset →
ER+ Breast CancerDormant
BBB
Indicative ·
75 / 100
View asset →
hormone receptor-positive breast cancerDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →